Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

PMCB PharmaCyte Biotech Inc

1,64

0,00 (0,00%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more PharmaCyte Biotech Charts.

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more PharmaCyte Biotech Charts.

News PharmaCyte Biotech Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 13 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 4 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mittwoch 13 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 13 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Montag 29 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 17 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 17 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 17 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 17 Juli 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Donnerstag 30 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Donnerstag 30 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 23 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Weitere PharmaCyte Biotech Inc News-Artikel

Intesa Sanpaolo

Visibilia Editore

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen